Barclays PLC boosted its stake in shares of TrueBlue, Inc. (NYSE:TBI - Free Report) by 95.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,353 shares of the business services provider's stock after buying an additional 32,940 shares during the quarter. Barclays PLC owned 0.23% of TrueBlue worth $531,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in TBI. Bank of New York Mellon Corp increased its stake in TrueBlue by 2.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 130,200 shares of the business services provider's stock worth $1,341,000 after buying an additional 2,905 shares during the period. XTX Topco Ltd increased its position in shares of TrueBlue by 19.4% during the second quarter. XTX Topco Ltd now owns 22,725 shares of the business services provider's stock worth $234,000 after acquiring an additional 3,689 shares during the period. Sei Investments Co. increased its position in shares of TrueBlue by 22.5% during the second quarter. Sei Investments Co. now owns 40,329 shares of the business services provider's stock worth $415,000 after acquiring an additional 7,400 shares during the period. Marshall Wace LLP raised its stake in shares of TrueBlue by 330.7% in the second quarter. Marshall Wace LLP now owns 143,910 shares of the business services provider's stock valued at $1,482,000 after acquiring an additional 110,495 shares in the last quarter. Finally, AQR Capital Management LLC grew its stake in TrueBlue by 7.5% during the 2nd quarter. AQR Capital Management LLC now owns 333,100 shares of the business services provider's stock worth $3,431,000 after purchasing an additional 23,315 shares in the last quarter. 97.15% of the stock is currently owned by institutional investors and hedge funds.
TrueBlue Stock Performance
Shares of NYSE:TBI traded down $0.21 on Friday, hitting $7.82. 113,149 shares of the company's stock were exchanged, compared to its average volume of 155,278. TrueBlue, Inc. has a 1-year low of $6.63 and a 1-year high of $14.91. The company has a market capitalization of $231.22 million, a PE ratio of -2.04, a P/E/G ratio of 3.48 and a beta of 1.43. The firm's 50-day moving average is $7.84 and its 200 day moving average is $8.28.
TrueBlue (NYSE:TBI - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The business services provider reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.04. The firm had revenue of $382.36 million during the quarter, compared to the consensus estimate of $386.07 million. TrueBlue had a negative return on equity of 2.69% and a negative net margin of 6.97%. The firm's quarterly revenue was down 19.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.16 earnings per share. On average, analysts anticipate that TrueBlue, Inc. will post -0.56 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research firms recently weighed in on TBI. BMO Capital Markets cut their target price on shares of TrueBlue from $11.00 to $10.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th. StockNews.com raised shares of TrueBlue from a "sell" rating to a "hold" rating in a research report on Friday, December 27th.
Get Our Latest Report on TBI
TrueBlue Company Profile
(
Free Report)
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Recommended Stories
Before you consider TrueBlue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.
While TrueBlue currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.